@article{TCR13012,
author = {Marie Lange and Florence Joly},
title = {Cognitive complaints in breast cancer patients treated with chemotherapy: a reality?},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 3},
year = {2017},
keywords = {},
abstract = {Memory and attention dysfunction is a common complaint among cancer survivors, named “chemobrain”, which can be reported during and even several years after treatment. These disorders have a negative impact on patients’ quality of life (1) and can disturb ability to work (2). Recent studies assessed self-reported cognitive function in cancer patient cohorts, mainly in breast cancer women, and showed that 46% to 60% of survivors had cognitive complaints (3-5). However, these studies did not use a validated questionnaire specifically constructed to assess cognitive complaints.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/13012}
}